On March 21, 2019 Cofactor Genomics reported that Natalie LaFranzo, the company’s Director of Scientific Projects and Market Development, reported that it will present at the 2019 Annual Meeting of the American Association for Cancer Research (AACR) (Free AACR Whitepaper) being held at the Georgia World Congress Center in Atlanta, GA (Press release, Cofactor Genomics, MAR 21, 2019, View Source [SID1234534535]). The presentation is scheduled to take place on Sunday, March 31, 2019, at in Session PO.TB06.04 – Gene Expression in the Tumor Microenvironment. The presentation features Predictive Immune Modeling and multidimensional biomarker data generated in collaboration with TriStar Technology Group, a leading provider of archived human bio specimens and related research services offering highly-characterized and well-curated donor samples with extensive clinical follow-up data.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Executives from the company including CEO, Jarret Glasscock, will be attending the meeting to engage with current and future collaborators, clients, and investors. Visit View Source to arrange a time to meet with executives from Cofactor. The company also continues to solicit applications for their ImmunoPrism Grant Program, closing April 15. The grant program offers researchers the first opportunity to access Cofactor’s Predictive Immune Modeling platform. More information on the grant program may be found here: View Source